| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5902391 | Journal of Diabetes and its Complications | 2015 | 4 Pages |
Abstract
Teneligliptin is one of the useful options for glycemic control in T2DM patients undergoing HD.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Noritsugu Wada, Katsuhito Mori, Chie Nakagawa, Jun Sawa, Yasuro Kumeda, Tetsuo Shoji, Masanori Emoto, Masaaki Inaba,